Veracyte, Inc. (VCYT) — Stock Score Summary

Veracyte, Inc. (VCYT) has a MoatMap StockRank of 89/100 based on Quality (72/100), Value (27/100), and Momentum (77/100) factor scores. The current signal is STRONG BUY. Veracyte is a high-quality genomic diagnostics company with high gross margins and a strong competitive moat. However, it lacks a direct connection to our 18-month macro themes, making it a candidate for monitoring rather than immediate high-conviction allocation.

Veracyte, Inc. is a global diagnostics company focused on genomic tests for difficult-to-diagnose diseases, particularly in oncology, pulmonology, and endocrinology. Its competitive moat lies in its proprietary genomic platforms and clinically validated tests that provide actionable insights, reducing the need for invasive procedures. Veracyte is a specialized diagnostics leader, benefiting from strong intellectual property and a growing portfolio of revenue-generating precision medicine tests.

Key Financial Metrics

Price$49.24
Market Cap$3.8B
P/E (TTM)46.24
P/E (Forward)26.27
Price/Book3.03
Return on Equity6.9%
Return on Invested Capital5.1%
Debt/Equity2.93
Gross Margin72.9%
Operating Margin16.3%
Revenue Growth21.5%
Free Cash Flow$105M

Veracyte, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Veracyte, Inc.’s (VCYT) StockRank?
MoatMap’s StockRank for Veracyte, Inc. (VCYT) is 89/100, with a Strong Buy signal. It is a composite of Quality (72), Value (27), and Momentum (77) factor ranks across MoatMap’s 19,000+ stock universe.
Does Veracyte, Inc. have an economic moat?
Veracyte, Inc. (VCYT) has a Quality factor score of 72/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Veracyte, Inc. a buy, hold, or sell?
MoatMap’s current signal for Veracyte, Inc. (VCYT) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Veracyte, Inc. in?
Veracyte, Inc. (VCYT) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksVCYT deep dive reportAI ChampionsHow we score stocksSense-check another stock